| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 04/18/2006 | US7029652 Administering dose of antiangiogenic cyclo-arginine-glycine-aspartic acid- containing pentapeptide (cRGD pentapeptide), radioimmunotherapeutic agent (RIT), and one additional dose of cRGD pentapeptide |
| 04/18/2006 | CA2431683C Migraine headache eye-rinse remedy solution |
| 04/13/2006 | WO2006038738A1 Receptor function regulating agent |
| 04/13/2006 | WO2006038596A1 Pharmaceutical composition for xerophthalmia and xerostomia treatment |
| 04/13/2006 | WO2006024770A3 Phosphole derivatives complexed with metals, and pharmaceutical uses thereof |
| 04/13/2006 | WO2006017347A3 Opthalmic compositions and methods for treating ophthalmic conditions |
| 04/13/2006 | US20060079670 98 human secreted proteins |
| 04/13/2006 | US20060079572 Novel bioactive substance |
| 04/13/2006 | US20060079563 Cyclic protein tyrosine kinase inhibitors |
| 04/13/2006 | US20060079551 Treatment of neurodegenerative diseases and cancer of the brain using histone deacetylase inhibitors |
| 04/13/2006 | US20060079548 Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 04/13/2006 | US20060079525 antiinflammatory agent N-{[(2S)-4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}cyclopropane carboxamide; bronchitis, asthma, chronic obstructive pulmonary disease and rhinitis |
| 04/13/2006 | US20060079489 Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine |
| 04/13/2006 | US20060078878 Cell containing nucleic acid molecule comprising polynucleotide sequence encoding engineered zinc finger protein operably linked to promoter, contacting target site in endogenous cellular gene with protein to inhibit transcription |
| 04/13/2006 | US20060078626 Opthalmic and contact lens solutions with a peroxide source and a cationic polymeric preservative |
| 04/13/2006 | US20060078582 Use of compositions for treating rosacea |
| 04/13/2006 | DE102004048877A1 New tricyclic thiazole derivatives useful as PI3 kinase inhibitors, for treating e.g. inflammatory and allergic airway and skin diseases, autoimmune and kidney disease |
| 04/13/2006 | CA2583326A1 Receptor function regulating agent |
| 04/13/2006 | CA2582615A1 Pharmaceutical composition for treatment of tear and salivary fluid drying |
| 04/12/2006 | EP1645276A1 Treatment of neurodegenerative disorders |
| 04/12/2006 | EP1644009A2 Compositions and methods for increasing telomerase activity |
| 04/12/2006 | EP1643997A1 Flupirtine preparation for treating neurodegenerative disorders of the visual system and diabetes mellitus |
| 04/12/2006 | EP1404174A4 Anti-infective compositions for treating disordered tissue such as cold sores |
| 04/12/2006 | EP1345920B1 Novel sulfamides and their use as endothelin receptor antagonists |
| 04/12/2006 | EP1331940B1 Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2 |
| 04/12/2006 | EP1144435B1 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 04/12/2006 | EP1140175B1 Antibodies to truncated vegf-d and uses thereof |
| 04/12/2006 | EP0938328B1 Method of inhibiting fibrosis with a somatostatin agonist |
| 04/12/2006 | EP0843549B1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene a 4 hydrolase inhibitor |
| 04/12/2006 | CN1758922A Eye-drop vaccine containing copolymer 1 for therapeutic immunization |
| 04/12/2006 | CN1758915A 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure |
| 04/12/2006 | CN1757414A Method for preparing visible polysaccharide membrane used as carrier of medicine for treating eye surface diseases |
| 04/12/2006 | CN1757402A Application of Ji-gan-san extractive total flavonoid for preparing medicine to treat ophthalmologic diseases |
| 04/12/2006 | CN1757389A Implanted agent for preventing and treating biabetic retinopathy |
| 04/12/2006 | CN1250280C Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 04/11/2006 | US7026505 Method of treating tinnitus |
| 04/11/2006 | US7026491 E.g., dimethylcarbamic acid, 2-oxo-3-benzyl-4-methyl-2H-1-benzopyran; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 04/11/2006 | US7026487 Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, a pyridyl group and an alkyl group, having retinoid-like biological activity |
| 04/11/2006 | US7026359 e.g., tridecafluoro-4,4-dimethyl-1-heptene trimer or 1H, 1H, 2H-perfluoro-1-octane trimer; causes little or no damage to the retina even when used over a long period. |
| 04/11/2006 | US7026352 Physiologically active substances |
| 04/11/2006 | US7026349 Sulfonamides |
| 04/11/2006 | US7026348 Antiinflammatory agents; sepsis shock; rheumatic diseases |
| 04/11/2006 | US7026336 4-pyridinylimidazol-2-ylhydrocarbyl amine, (thio)urea, carbamic acid or sulfonamide derivatives, e.g., (2-(4-(4-Chloro-3-methoxy-phenyl)-5-pyridin-4-yl-1H-imidazol-2-yl)-2-methyl-propyl)-carbamic acid tert-butyl ester; Raf kinase inhibitors for the treatment of neurotraumatic diseases |
| 04/11/2006 | US7026326 Substituted heterocyclic compounds and methods of use |
| 04/11/2006 | US7026319 Use of vitamin combination for the treatment of pruritus and non-infective disorders involving itching and/or inflammation |
| 04/11/2006 | US7026316 (optionally aza)cycloalkyl-N,N-optionally thia-, oxothia- or dioxothia-)alkyleneglycine derivatives, e.g., N-{4-[(1S)-1-amino-2-oxo-2-(1,3-thiazolidin-3-yl)ethyl]cyclohexyl}-N'-hexylureA; especially treating type 2 diabetes |
| 04/11/2006 | US7026300 One step immunization procedure for inducing a Chlamydia specific immune response |
| 04/11/2006 | US7026296 Prevent cytokine biosynthesis; topical applying to eye |
| 04/11/2006 | US7025987 Delivery system for nucleic acids |
| 04/11/2006 | US7025960 For therapy of diseases which can be treated or alleviated by a stimulation of the production of cytokines, particularly of IL-12 |
| 04/11/2006 | CA2411008C Derivatives of 2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione |
| 04/11/2006 | CA2204375C Methods for the diagnosis of glaucoma |
| 04/06/2006 | WO2006037106A2 Carboxy-amido-triazoles for the localized treatment of ocular diseases |
| 04/06/2006 | WO2006036031A1 Fused furan derivative and use thereof |
| 04/06/2006 | WO2006035969A1 Ophthalmic composition containing xanthan gum and amino acid |
| 04/06/2006 | WO2006035954A1 Carbostyril compound |
| 04/06/2006 | US20060074244 Pyridinyl substituted (1,2,3,)triazoles as inhibitors of the tgf-beta signalling pathway |
| 04/06/2006 | US20060074233 Detect binding with cells transfected with DNA |
| 04/06/2006 | US20060074129 Method for obtaining ozonized oils and vegetable fats and use of said products for pharmaceutical and cosmetic purposes |
| 04/06/2006 | US20060074123 Cyclic AMP-specific phosphodiesterase inhibitors |
| 04/06/2006 | US20060074112 N-aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors |
| 04/06/2006 | US20060074090 1,2,5-Thiadiazol-3-yl-piperazine therapeutic agents useful for treating pain, depression and anxiety |
| 04/06/2006 | US20060074058 Combination of dpp iv inhibitor and a cardiovascular compound |
| 04/06/2006 | US20060074053 Ophthalmic solution containing quinolone antimicrobial compound |
| 04/06/2006 | DE10231370B4 Thiophenglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel Thiophenglycosidderivate, pharmaceutical compositions containing them and methods for making these drugs |
| 04/06/2006 | CA2581126A1 Carboxy-amido-triazoles for the localized treatment of ocular diseases |
| 04/06/2006 | CA2580811A1 Carbostyril compound |
| 04/05/2006 | EP1642888A1 compounds for modulating the rage receptor |
| 04/05/2006 | EP1642581A2 Treatment of retinal diseases with quinoxaline derivatives |
| 04/05/2006 | EP1641472A2 Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide |
| 04/05/2006 | EP1641435A2 Rate controlled release of a pharmaceutical agent in a biodegradable device |
| 04/05/2006 | EP1485084B1 Use of an l-ascorbic acid salt to prepare a pharmaceutical composition for ophthalmic topical use capable of improving the level of l-ascorbic acid in the eye |
| 04/05/2006 | EP1438104B1 Co-cycloalkyl 17-heteroaryl prostaglandin e2 analogs as ep2-receptor agonists |
| 04/05/2006 | EP1392308B1 Ophthalmically acceptable compositions comprising an alpha-2-adrenergic agonist and a fatty acid |
| 04/05/2006 | EP1383522B1 A medicament or a dressing containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use in the treatment of inflammatory skin conditions |
| 04/05/2006 | EP1305319B1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 04/05/2006 | EP1280524B1 Methods and compositions for modulating alpha adrenergic receptor activity |
| 04/05/2006 | EP1086098B1 Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists |
| 04/05/2006 | CN1249059C Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
| 04/05/2006 | CN1249051C Muscarinic agonists |
| 04/05/2006 | CN1249039C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type I |
| 04/05/2006 | CN1249033C Cyclic amp-specific phosphodiesterase inhibitors |
| 04/04/2006 | US7022870 Antidepressants; sexual disorders; anticancer agnets; hormone replacement therapy |
| 04/04/2006 | US7022856 Carboline derivatives |
| 04/04/2006 | US7022740 Lubricious ophthalmic solutions |
| 04/04/2006 | US7022738 (3S)-N-butyl-3-((2S)-2-(((4-fluorophenyl)sulfonyl)amino)-3-methylbutanoylamino)-5-methyl-2-oxohexanamide; calpain inhibition; Alzheimer's, osteoporosis, brain and eye disorders, ischemia |
| 04/04/2006 | US7022729 For treating central nervous system disorders, immunomodulatory disorders, antimalaria, viral disease of Borna virus, Hepatitis; a 6-azatricyclo(6.3.1.01,6)dodecane derivatives |
| 04/04/2006 | US7022726 ω-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists |
| 04/04/2006 | US7022716 Cyclic amine phenyl beta-3 adrenergic receptor agonists |
| 04/04/2006 | US7022711 2-(4-Pyridyl)amino-6-dialkoxyphenyl-pyrido[2,3-d]pyrimidin-7-ones |
| 04/04/2006 | US7022690 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 04/04/2006 | US7022687 for treatment of allergies and airway disorders such as allergic rhinitis |
| 04/04/2006 | US7022521 Methods and compositions for treating platelet-related disorders using MPL pathway inhibitory agents |
| 03/30/2006 | WO2006033734A2 Combination compositions comprising 13-cis-retinyl derivatives and uses thereof to treat opthalmic disorders |
| 03/30/2006 | WO2003014294A3 Tacis and br3 polypeptides and uses thereof |
| 03/30/2006 | US20060069162 Transparent eye drops containing latanoprost |
| 03/30/2006 | US20060069148 Prostaglandins for prostaglandin mediated diseases such as antihistamines |
| 03/30/2006 | US20060069131 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 03/30/2006 | US20060069092 Pharmaceutical compositions for the treatment of diseases related to neurotrophines |
| 03/30/2006 | US20060069084 Methods of inhibiting kinases |